RIEFLIN WILLIAM JL 4
4 · Lyell Immunopharma, Inc. · Filed Jun 10, 2022
Insider Transaction Report
Form 4
RIEFLIN WILLIAM JL
Director
Transactions
- Award
Option (right to buy)
2022-06-08+65,000→ 65,000 totalExercise: $5.31Exp: 2032-06-07→ Common Stock (65,000 underlying)
Footnotes (1)
- [F1]The option shares shall vest on the earlier of (a) the date of the next annual meeting of the stockholders that occurs following June 8, 2022 (or the date immediately prior to such date if the Reporting Person's service as a director ends at such annual meeting due to the Reporting Person's failure to be reelected or the Reporting Person not standing for re-election); or (b) the first anniversary of June 8, 2022, subject to the Reporting Person providing continuous service through such date.